New Concepts in the Management of Medullary Thyroid Cancer - Management of MEN2
This live webinar series is an educational program that addresses health care professionals' need to be educated on current and emerging evidence-based scientific data for accurate and timely clinical evaluation of patients with medullary thyroid cancer (MTC). Participants will learn how to implement the NCCN Guidelines recommendations into their practice and gain a clear understanding of the most current treatment recommendations for MTC and MEN2.
This webinar series is designed to meet the educational needs of medical oncologists, surgical oncologists, radiation oncologists, endocrinologists, nurses, pharmacists, and other healthcare professionals who manage patients with thyroid cancer.
- Summarize the recommendations for genetic testing and early intervention for patients with inherited MEN2 who are at risk for MTC
- Recognize the different levels of risk for acquiring MTC for patients with specific RET gene mutations
Whitney S. Goldner, MD
Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center
This activity is approved for AMA PRA Category 1 Credit(s)™. Nursing and pharmacy (ACPE) credits are also provided. View complete accreditation information
- 1.00 Participation
- 1.00 Nurse
- 1.00 Pharmacist
- 1.00 Physician